Antimicrobial resistance (AMR): stemming the rise and spread of drug-resistant infection
The LSHTM-Charité Global Health Lecture Series brings together leading scientists from the UK, Germany and further afield to present cutting-edge research on pressing global health issues and to discuss the implications of their work for policy and practice.
This seminar has been postponed due to unforeseen circumstances. We apologise for any inconvenience this may cause.
The second event of the LSHTM-Charité Global Health Lecture Series will focus on Antimicrobial resistance (AMR).
Prof Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance, Prof Heike Brötz-Oesterhelt, Chair of the Department of Microbial Bioactive Compounds at the University of Tübingen and Prof Jyoti Joshi, Head of South Asia at the Center for Disease Dynamics, Economics & Policy (CDDEP) will speak at the event, providing insight into the state of current research, exploring multi-disciplinary approaches including the ‘One Health’ approach to tackling antimicrobial resistance, and discussing policy tensions and implementation challenges that exist. Prof Veronika von Messling, Director-General for Life Sciences at the German Federal Ministry of Education and Research, will chair the event and will provide reflections on the policy context in Germany.
Key questions guiding the event will be:
- Why are drug-resistant infections such an urgent and complex threat to global health?
- What is being done across disciplines and sectors to stem the rise and spread of drug-resistant infection and what challenges have been faced?
- What advances in research and at the level of policy are needed to address current gaps?
About the speakers
- Prof Veronika von Messling (Chair)
Prof Veronika von Messling is Director-General for Life Sciences at the German Federal Ministry of Education and Research. She obtained her veterinary degree and her doctorate degree in veterinary virology from the Veterinary School Hannover, Germany. After postdoctoral training at Mayo Clinic in Rochester, MN, she was Assistant Professor at INRS-Institut Armand-Frappier in Laval, QC, and then Associate Professor at Duke-NUS Medical School, Singapore, before becoming Director of the Veterinary Division at Paul-Ehrlich-Institute, the German Federal Institute of Vaccines and Biomedicines, in Langen, Germany. Her expertise lies in the development of novel prophylactic and therapeutic strategies against infectious diseases.
- Prof Dame Sally Davies
Prof Dame Sally Davies was appointed as the UK Government’s Special Envoy on AMR in 2019. She is also the 40th Master of Trinity College, Cambridge University. She joined the College after a distinguished career as a clinical academic and public servant. Dame Sally graduated from Manchester Medical School in 1972 and became a Consultant Haematologist specialising in sickle cell disease. In 1997 she was appointed as Honorary Professor of Haemoglobinopathies at Imperial College. Dame Sally was the Chief Medical Officer for England and Senior Medical Advisor to the UK Government from 2011-2019. She authorised 11 independent annual reports and 3 special reports: Medical Cannabis, Screen Times for Children and Obesity in Childhood. She has become a leading figure in global health including serving as a member of the World Health Organisation (WHO) Executive Board 2014-2016 and as co-convener of the United Nations Inter-Agency Co-ordination Group (IACG) on Antimicrobial Resistance (AMR) reporting in 2019. She has championed the need to address AMR across all sections: human and animal health, agriculture and environment within the UN family and globally. In the 2020 New Year Honours, Dame Sally became the second woman (and the first outside the Royal family) to be appointed Dame Grand Cross of the Order of the Bath (GCB) for services to public health and research having received her DBE in 2009. She was elected Fellow of the Royal Society in 2014 and a member of the National Academy of Medicine, USA in 2015. She has been awarded more than 30 honorary doctorate degrees.
- Prof Heike Brötz-Oesterhelt
Prof Heike Brötz-Oesterhelt is a microbiologist by training. For more than 20 years, she has been working in antibacterial drug discovery in the academic as well as in the pharmaceutical industry setting. After her PhD, she joined the Anti-Infectives Department of Bayer HealthCare in Wuppertal as research scientist and project leader. After 8 years in “big pharma”, she co-founded the Biotech company AiCuris. In 2010, she returned to academia as a professor for Pharmaceutical Biology at the University of Düsseldorf, and since 2014 she is full professor for Microbiology at the University of Tübingen heading the Department of Microbial Bioactive Compounds. Currently, she is managing director of the Interfaculty Institute of Microbiology and Infection Medicine, Tübingen, speaker of the Transregional Collaborative Research Centre TRR261 “Molecular Mechanism of Antibiotic Action and Production”, co-speaker of the Cluster of Excellence “Controlling Microbes to Fight Infection” (both funded by the German Research Organisation DFG) as well as deputy speaker of the partner site Tübingen within the German Center of Infection Research (DZIF). Heike Brötz-Oesterhelt is particularly interested in molecular mechanisms of new antibiotic lead structures and operation modes of novel antibiotic targets.
- Prof Jyoti Joshi
Prof Jyoti Joshi is Head of South Asia at the Center for Disease Dynamics, Economics & Policy (CDDEP) and an Adjunct Professor at Amity Institute of Public Health, Amity University, India. She is a medical doctor with specialization in Community Medicine and Infectious diseases. Jyoti has worked with government health programs for almost two decades and her research interests include antimicrobial resistance (AMR), vaccines & infectious diseases and health systems. As the South Asia lead for the Global Antibiotic Research Partnership (GARP) project, she supported the development of in-country policy analysis capacity to address AMR in low and middle income countries (LMIC) in Asia. Jyoti serves as a Board member for SEDRIC (Surveillance and Epidemiology of Drug Resistant Infections Consortium), a think tank of experts, established by the Wellcome Trust to share expertise and take action to tackle the gaps in drug-resistant infections surveillance and epidemiology. In her current role , she has worked with World Health Organisation (WHO) on several projects such as undertake country case studies and develop global guidance for implementing National Action Plans for AMR and translating them from paper to the field by integrating AMR sensitive and AMR specific approaches within the existing health programs.
Opening Prof Veronika von Messling
Director-General for Life Sciences at the German Federal Ministry of Education and Research (BMBF)
Presentations Prof Dame Sally Davies
UK Special Envoy on Antimicrobial Resistance
Prof Heike Brötz-Oesterhelt
Chair of the Department of Microbial Bioactive Compounds, University of Tübingen
Prof Jyoti Joshi
Head of South Asia, Center for Disease Dynamics, Economics & Policy (CDDEP)
Discussion Q&A and discussion with the audience
Closing Reception with refreshments
The session will be recorded and made available after the event on the LSHTM Vimeo channel.
The LSHTM-Charité Global Health Lecture Series is supported by the Bill & Melinda Gates Foundation and this event on Pandemic Preparedness is also supported by the Wellcome Trust.